• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

Page 29 of 37
A dose of good news: Pfizer shares surge on coronavirus vaccine trial
FinanceA dose of good news: Pfizer shares surge on coronavirus vaccine trial
By Rey MashayekhiJuly 1, 2020
Telehealth Ro Pfizer Viagra
HealthTelehealth startup Ro partners with Pfizer to give its ED business a boost
By Sy MukherjeeJanuary 24, 2020
Fitbit BMS Pfizer AFib
NewslettersFitbit Teams Up With Drug Giants to Tackle a Serious Heart Condition: Brainstorm Health
By Sy MukherjeeOctober 17, 2019
Pfizer New York Headquarters - Pfizer announced a $14
HealthPfizer Betting Big on Cancer Research in $11.4 Billion Acquisition of Array BioPharma
By The Associated PressJune 17, 2019
Freda Lewis-Hall of Pfizer and Toby Cosgrove of the Cleveland Clinic and Google Cloud at the 2019 Fortune Brainstorm Health conference in San Diego.
TechData Sheet–Drug Discovery Shifting From Treatment to Cure
By Aaron Pressman and Adam LashinskyApril 4, 2019
Viagra
HealthViagra Sales Are Down. Here’s Why Pfizer Maintains Its Market Lead Anyway
By Brittany ShootFebruary 14, 2019
Pfizer Acquires Wyeth For $68 Billion
HealthPfizer’s Best-Selling Drug Is Actually a Vaccine—and Its Price Keeps Increasing
By Brittany ShootFebruary 5, 2019
Prescription bottles.
HealthNet Drug Prices Are Falling, Even as List Prices Increase
By Renae ReintsJanuary 30, 2019
Midsection of mature male pharmacist holding prescription paper and medicine standing by drawer at store
HealthPrescription Drug Companies Are Raising Prices on Older Medicines
By Erik ShermanJanuary 18, 2019
Under Pressure For Trump, Pfizer Agrees To Lower Drug Prices
Pfizer Offers Early Retirement to U.S. Employees Ahead of Layoffs
By Renae ReintsOctober 17, 2018
Biotech IPO Allogene
HealthWhy Cancer Biotech Allogene Just Scored an Eye Popping $324 Million IPO
By Sy MukherjeeOctober 11, 2018
CNBC Events
HealthPfizer CEO Ian Read to Step Aside Next Year for Albert Bourla to Take the Reins
By Don ReisingerOctober 1, 2018
EpiPen shortage Walgreens Auvi-Q
HealthThere’s Still a Big EpiPen Shortage—But Walgreens Will Start Selling a Competing Product
By Sy MukherjeeSeptember 7, 2018
Children's Advil Cold medicine and dosage chart.
HealthPfizer Recalls Children’s Advil Product After Its Measuring Cup Confused Milliliters With Teaspoons
By Glenn FleishmanAugust 27, 2018
FDA EpiPen generic
HealthThe FDA Finally Approved an EpiPen Generic. But a Shortage Looms Ahead of the School Year
By Sy MukherjeeAugust 16, 2018
1...
  • 27
  • 28
  • 29
  • 30
  • 31
...37
Most Popular
Economy
U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
Economy
The U.S. had a national debt ‘home run’ in its grasp, says Jamie Dimon. But the government did nothing, and now its best option is crisis managementplaceholder alt text
By Fortune EditorsApril 8, 2026
Energy
2 years ago, Saudi Arabia quietly canceled the ‘petrodollar’ deal with America that wired the world economy for 50 years. Then war broke out in Iranplaceholder alt text
By Fortune EditorsApril 7, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.